Found 11 matching trials
A Phase 1 Study of PROT-001.
PHASE1A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Location
Nucleus Network Pty Ltd
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport
PHASE1This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Location
ICON Early Phase Services
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
PHASE1This is a Phase 1, open-label, 3-period study to determine radiprodil's pot...
Location
Nucleus Network Melbourne
VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)
PHASE1This study will assess safety, tolerability and pharmacokinetic (PK) of VH3...
Location
GSK Investigational Site
A Study of Multiple Doses of Lasmiditan in Healthy Participants
PHASE1The purpose of this study is to look at how much lasmiditan, study drug, ge...
Location
Covance Daytona Beach
A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol
PHASE1Primary Objective:
To assess the effect of repeated once-daily oral doses ...
Location
Investigational Site Number 840001
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir
PHASE1The purpose of this study is to assess the effect of multiple doses of gana...
Location
Novartis Investigative Site
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates
PHASE1This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Location
Syneos Health Clinical Research Services, LLC.
Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation
PHASE1The purpose of this study is to identify and validate a probe cocktail for ...
Location
GSK Investigational Site
BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
PHASE1This is a prospective, open label, two-centre, randomized, controlled, two-...
Location
TASK Applied Sciences Clinical Research Centre